Steve O'loughlin - Net Worth and Insider Trading

Steve O'loughlin Net Worth

The estimated net worth of Steve O'loughlin is at least $2,165 dollars as of 2024-11-07. Steve O'loughlin is the Principal Financial Officer of Actinium Pharmaceuticals Inc and owns about 1,183 shares of Actinium Pharmaceuticals Inc (ATNM) stock worth over $2,165. Details can be seen in Steve O'loughlin's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Steve O'loughlin has not made any transactions after 2018-12-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Steve O'loughlin

To

Steve O'loughlin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Steve O'loughlin owns 1 companies in total, including Actinium Pharmaceuticals Inc (ATNM) .

Click here to see the complete history of Steve O'loughlin’s form 4 insider trades.

Insider Ownership Summary of Steve O'loughlin

Ticker Comapny Transaction Date Type of Owner
ATNM Actinium Pharmaceuticals Inc 2018-12-10 VP & Finance and Corporate Dev.

Steve O'loughlin Latest Holdings Summary

Steve O'loughlin currently owns a total of 1 stock. Steve O'loughlin owns 1,183 shares of Actinium Pharmaceuticals Inc (ATNM) as of December 10, 2018, with a value of $2,165.

Latest Holdings of Steve O'loughlin

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ATNM Actinium Pharmaceuticals Inc 2018-12-10 1,183 1.83 2,165

Holding Weightings of Steve O'loughlin


Steve O'loughlin Form 4 Trading Tracker

According to the SEC Form 4 filings, Steve O'loughlin has made a total of 0 transactions in Actinium Pharmaceuticals Inc (ATNM) over the past 5 years. The most-recent trade in Actinium Pharmaceuticals Inc is the acquisition of 333 shares on December 10, 2018, which cost Steve O'loughlin around $4,400.

Insider Trading History of Steve O'loughlin

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Steve O'loughlin Trading Performance

GuruFocus tracks the stock performance after each of Steve O'loughlin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Steve O'loughlin is 8.26%. GuruFocus also compares Steve O'loughlin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Steve O'loughlin within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Steve O'loughlin's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Steve O'loughlin

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 16.07 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 15.96 LIMIT LIMIT LIMIT LIMIT LIMIT

Steve O'loughlin Ownership Network

Ownership Network List of Steve O'loughlin

No Data

Ownership Network Relation of Steve O'loughlin

Insider Network Chart

Steve O'loughlin Owned Company Details

What does Actinium Pharmaceuticals Inc do?

Who are the key executives at Actinium Pharmaceuticals Inc?

Steve O'loughlin is the VP & Finance and Corporate Dev. of Actinium Pharmaceuticals Inc. Other key executives at Actinium Pharmaceuticals Inc include Chief Scientific Officer Dale L. Ludwig , Chief Commercial Officer Anil Kapur , and Executive Vice President Nitya G. Ray .

Actinium Pharmaceuticals Inc (ATNM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Actinium Pharmaceuticals Inc (ATNM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Actinium Pharmaceuticals Inc (ATNM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Actinium Pharmaceuticals Inc (ATNM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Actinium Pharmaceuticals Inc Insider Transactions

No Available Data

Steve O'loughlin Mailing Address

Above is the net worth, insider trading, and ownership report for Steve O'loughlin. You might contact Steve O'loughlin via mailing address: 955 Hartman Run Road, Morgantown Wv 26507.